ELISABETH ANDERSON: Open Payments
NPI 1518955624 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 27 payments from 17 companies in 2025. Trend: 2023 $680 · 2024 $682 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $79 |
| ABBVIE INC. | 4 | $73 |
| Amgen Inc. | 1 | $59 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| PFIZER INC. | 2 | $44 |
| SANOFI-AVENTIS U.S. LLC | 2 | $43 |
| Dynavax Technologies Corporation | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Inspire Medical Systems, Inc. | 1 | $23 |
Products named: UPTRAVI, VRAYLAR, EVENITY, TRELEGY ELLIPTA, NURTEC ODT, TZIELD, Heplisav-B, FARXIGA.
Industry payments across UT — which companies pay providers there.
